ANXA2 enhances HCC growth by up-regulating cell proliferation without significant apoptosis enhancement.
ANXA2 enhances the HCC cell motility by up-regulating expression and polymerization of cell microstructure associated proteins, F-actin, β-tubulin and lamin B.
ANXA2 enhances HCC metastasis by introducing development of the cell psuedopodia/filapodia closely associated with cell motility and contact inhibition.
Take above together, ANXA2 enhances malignancy of HCC cells by remodeling motility associated microstructures.